Close Menu

NEW YORK (360Dx) – Genomic Vision said that its third quarter revenues grew 27 percent year over year with a sharp spike in in vitro diagnostic sales. The firm posted total revenues of €701,000 ($825,000) for the three months ending on Sept. 30, up from €550,000 in Q3 2016.

Total revenues grew to €512,000 from €231,000 a year ago. Within that, life science research sales rose to €161,000 from €133,000, while IVD sales climbed to €276,000 from €16,000, and revenues from Quest Diagnostics R&D decreased to €75,000 from €82,000 a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.